SEARCH RESULTS FOR: "Tag: PBYI"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(4)
2017(7)
2016(5)
2015(1)
2014(1)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(1)
Analyst Update(5)
Best and Worst Stocks(1)
Buzz Stocks(2)
By the Numbers(2)
General(1)
Indexes and ETFs(1)
Intraday Option Activity(2)
Midday Market Check(4)
Quantitative Analysis(1)
Stock Market News(2)
Stocks On the Move(2)
Technical Analysis(1)

10/8/2019 9:56 AM
Goldman Sachs downgraded Puma Biotechnology Inc (NASDAQ:PBYI) stock to "sell" from "neutral," and slashed its price target to $8 from $24 -- a 20.6% discount to last night's close. The brokerage firm...
4/1/2019 2:36 PM
The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are down 9.3% to trade at $35.29, one of the worst stocks on the Nasdaq today, after the company inked an exclusive licensing deal with Pierre Fabre ...
12/18/2018 10:33 AM
Shares of Puma Biotechnology Inc (NASDAQ:PBYI) are up 6.9% at $22.90, after the company announced successful results of the Phase III NALA trial for its experimental breast cancer drug, neratinib. An...
11/2/2018 1:37 PM
Stocks came back with a bang this week, though it wasn't enough to save the Dow from its worst monthly loss since January 2016. While news the U.S. was considering more tariffs on Chinese goods spoo...
11/2/2018 10:25 AM
While Apple (AAPL) earnings are dominating headlines today, a handful of biotech stocks are also swimming in red ink. In fact, Puma Biotechnology Inc (NASDAQ:PBYI) has surrendered half its value ...
 
Special Offers from Schaeffer's Trading Partners